Home - Products - Cell Cycle/DNA Damage - ROCK - MD 39-AM

MD 39-AM

CAS No. 72564-74-0

MD 39-AM( MD-39-AM | MD 39 AM | MD39AM )

Catalog No. M17581 CAS No. 72564-74-0

Anticytokinin activity was evaluated by 50% of the callus growth on the medium with kinetin but without anti-cytokinin

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	82	In Stock
2MG	36	In Stock
5MG	55	In Stock
10MG	86	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

MD 39-AM
Note

Research use only, not for human use.
Brief Description

Anticytokinin activity was evaluated by 50% of the callus growth on the medium with kinetin but without anti-cytokinin
Description

MD-39-AM is a diuretic agent, impling an increase in the Na+ excretion and showing antihypertensive effect.
In Vitro

——
In Vivo

——
Synonyms

MD-39-AM | MD 39 AM | MD39AM
Pathway

Cell Cycle/DNA Damage
Target

ROCK
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

72564-74-0
Formula Weight

268.34
Molecular Formula

C14H12N4S
Purity

>98% (HPLC)
Solubility

——
SMILES

CSc1nc2c(cccn2)c(n1)Nc1ccccc1
Chemical Name

2-Methylsulfanyl-N-phenylpyrido[2,3-d]pyrimidin-4-amine

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Pérez MJ, et al. Preliminary pharmacokinetics of a new pyridopyrimidine derivative. Arzneimittelforschung. 1991 Jun;41(6):640-4.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

CAY10746

CAY10746 is a selective Rho kinase (ROCK) inhibitor, targeting ROCK I and ROCK II with IC50 values of 0.014 μM and 0.003 μM, respectively.
BDP9066

BDP9066 is a potent and selective MRCK inhibitor that inhibits MRCKβ and MRCKα/β and can be used for the prevention and treatment of skin cancer.
CLINODISIDE A

Clinodiside A in rats with one compartment open model into the body, rapid distribution, elimination rate.

Sign In Join Free